FSD Pharma Inc.

NASDAQ:HUGE

0.0899 (USD) • At close August 14, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q2
Revenue 0000000000000000.00800.1590.010.0140.0140.0010.0110.02200000000
Cost of Revenue 0.120.1260.1451.1221.131.1591.0821.12300000000.57901.1640.7420000000000000
Gross Profit -0.12-0.126-0.145-1.122-1.13-1.159-1.082-1.1230000000-0.5710-1.005-0.7330.0140.0140.0010.0110.02200000000
Gross Profit Ratio 000000000000000-68.2160-6.314-75.761111100000000
Reseach & Development Expenses 0.16-0.031-0.0331.6112.3122.6951.8671.4120.9370.852-0.1073.6131.972.4933.4881.520.284000000000000000
General & Administrative Expenses 1.9731.8093.1982.7445.8572.8074.2415.3223.6114.1594.2358.0946.8812.6477.9232.2124.9867.1527.4827.081.9114.7041.4852.6322.6980.0050.0060.0030.0140.0010.0130.008
Selling & Marketing Expenses -0.0090.161000000000000000-1.8850.3300.7991.1440.7070.0020.0020000000
SG&A 1.9641.973.1982.7445.8572.8074.2415.3223.6114.1594.2358.0946.8812.6477.9232.2124.9865.2667.8137.082.7095.8482.1922.6342.7010.0050.0060.0030.0140.0010.0130.008
Other Expenses 002.0121.1071.131.1581.1461.1321.1011.1071.0050.040.0120.4230.1940.0520.0131.8431.103-0.2450.109-0.178-0.15900.0310000000
Operating Expenses 2.1241.9393.3125.4629.2996.667.2547.8665.656.1195.13312.6899.8036.19313.0644.76.1817.118.9167.2172.7726.0282.3472.6342.7450.0050.0060.0030.0140.0010.0130.008
Operating Income -2.243-2.065-3.312-8.832-9.845-6.66-7.254-7.866-5.65-6.119-5.133-12.689-9.803-6.193-13.064-4.7-6.265-8.283-9.726-7.448-2.6493.217-2.337-2.612-2.745-0.005-0.006-0.003-0.009-0.001-0.013-0.008
Operating Income Ratio 000000000000000-561.7870-52.03-1,005.468-528.517-191.2154,107.423-218.245-116.96600000000
Total Other Income Expenses Net 0.1660.4132.1813.341-0.1130.5110.125-0.10.189-0.044-0.482-0.0650.3972.0590.7480.774-0.963-6.461-1.387-4.6920.082-9.2445.322-0.29300000000
Income Before Tax -2.082-1.697-1.131-5.49-9.958-6.148-7.129-7.966-5.461-6.163-5.615-12.754-9.406-4.134-12.316-3.821-7.648-14.744-12.578-10.851-1.721-15.2712.9853.09-2.714-0.005-0.006-0.003-0.014-0.001-0.013-0.008
Income Before Tax Ratio 000000000000000-456.6730-92.614-1,300.331-770.029-124.183-19,500.023278.854138.38800000000
Income Tax Expense -0.187-0-0.1692.9270.93-0.209-0.038-3.4560.3220.20.6560.5390.129-1.2350.543-0.3422.5386.6982.8523.398-1.96718.488-10.644-11.404-0.0310000.005000
Net Income -1.895-1.697-1.131-8.417-10.888-5.94-7.091-4.51-5.783-6.348-5.791-13.207-9.939-4.569-13.473-4.372-8.775-14.744-12.578-10.851-1.721-15.2712.9853.09-2.714-0.005-0.006-0.003-0.014-0.001-0.013-0.008
Net Income Ratio 000000000000000-522.6250-92.614-1,300.331-770.029-124.183-19,500.023278.854138.38800000000
EPS -0.048-0.043-0.029-0.21-0.28-0.15-0.19-0.12-0.14-0.18-0.16-0.37-0.37-0.36-1.06-0.48-1.08-2.19-1.66-1.55-0.25-2.320.46-0.61-0.41-0.001-0.001-0.0010-0-0.002-0.001
EPS Diluted -0.048-0.043-0.029-0.21-0.28-0.15-0.19-0.12-0.14-0.18-0.16-0.37-0.37-0.36-1.06-0.48-1.08-2.19-1.66-1.55-0.25-2.320.39-0.61-0.41-0.001-0.001-0.0010-0-0.002-0.001
EBITDA -2.124-1.529-3.165-4.383-8.827-5.203-6.005-6.731-4.343-5.026-4.128-11.753-8.84-4.782-11.375-2.863-7.115-6.903-10.045-7.271-0.874-5.9693.018-2.905-2.67-0.005-0.006-0.003-0.014-0.001-0.013-0.008
EBITDA Ratio 000000000000000-439.870-43.359-880.733-516.001-263.6084,182.06-712.268-372.31900000000